BDBM103353 US8552202, Compound 5

SMILES C[C@H]1CC[C@@H](CC1)[C@H](NC(=O)c1ccccc1)C(=O)N1C[C@H](F)[C@H]2OCC(=O)[C@@H]12

InChI Key InChIKey=KLJDDHMAENWYIR-UHFFFAOYSA-N

Data  5 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 103353   

TargetCathepsin S(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM103353(US8552202, Compound 5)
Affinity DataKi:  28nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin K(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM103353(US8552202, Compound 5)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProcathepsin L(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM103353(US8552202, Compound 5)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin B(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM103353(US8552202, Compound 5)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCathepsin L2(Human)
Amura Therapeutics

US Patent
LigandPNGBDBM103353(US8552202, Compound 5)
Affinity DataKi: >1.00E+4nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails
US Patent